1
Exhibit 99.2
LIGGETT GROUP INC.
CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 1998
2
INDEX
PAGE
PART I FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
Liggett Group Inc.:
-------------------
Consolidated Balance Sheets as of June 30, 1998 and
December 31, 1997.............................................. 3
Consolidated Statements of Operations for the three and six
months ended June 30, 1998 and 1997............................ 5
Consolidated Statement of Stockholder's Equity (Deficit) for
the six months ended June 30, 1998............................. 6
Consolidated Statements of Cash Flows for the six months
ended June 30, 1998 and 1997................................... 7
Notes to Consolidated Financial Statements......................... 8
Eve Holdings Inc.:
------------------
Balance Sheets as of June 30, 1998 and December 31, 1997........... 24
Statements of Operations for the three and six months ended
June 30, 1998 and 1997......................................... 25
Statements of Cash Flows for the six months ended June 30,
1998 and 1997.................................................. 26
Notes to Financial Statements...................................... 27
-2-
3
PART I - FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
LIGGETT GROUP INC.
CONSOLIDATED BALANCE SHEETS
(Unaudited)
(Dollars in thousands, except per share amounts)
June 30, December 31,
1998 1997
------- -------
ASSETS
Current assets:
Cash ....................................................... $ 582 $ --
Accounts receivable:
Trade, less allowances of $529 and $1,062, respectively 11,384 9,572
Other .................................................. 991 743
Inventories ................................................ 31,549 35,057
Other current assets ....................................... 719 738
------- -------
Total current assets ............................... 45,225 46,110
Property, plant and equipment, at cost, less accumulated
depreciation of $29,702 and $29,452, respectively .......... 16,673 17,756
Intangible assets, at cost, less accumulated amortization
of $19,845 and $19,111, respectively ....................... 750 1,609
Other assets and deferred charges, at cost, less accumulated
amortization of $11,671 and $9,000, respectively ........... 3,674 3,000
------- -------
Total assets ....................................... $66,322 $68,475
======= =======
(continued)
3
4
LIGGETT GROUP INC.
CONSOLIDATED BALANCE SHEETS (Continued)
(Unaudited)
(Dollars in thousands, except per share amounts)
June 30, December 31,
1998 1997
--------- ---------
LIABILITIES AND STOCKHOLDER'S EQUITY (DEFICIT)
Current liabilities:
Current maturities of long-term debt ................................... $ 167,458 $ 28
Cash overdraft ......................................................... -- 891
Accounts payable, principally trade .................................... 5,974 6,413
Accrued expenses:
Promotional ........................................................ 22,891 26,993
Taxes, principally excise taxes .................................... 3,347 3,643
Estimated allowance for sales returns .............................. 4,750 4,750
Interest ........................................................... 8,067 8,070
Settlement accruals ................................................ 2,936 4,030
Other .............................................................. 6,586 8,834
--------- ---------
Total current liabilities ...................................... 222,009 63,652
Long-term debt, less current maturities ..................................... -- 168,112
Non-current employee benefits and other liabilities ......................... 11,357 11,168
Other long-term liabilities ................................................. 21,328 18,400
Commitments and contingencies (Notes 5 and 8)
Stockholder's equity (deficit):
Redeemable preferred stock (par value $1.00 per share; authorized 1,000
shares; no shares issued and outstanding)
Common stock (par value $0.10 per share; authorized 2,000 shares; issued
and outstanding 1,000 shares)
and contributed capital .............................................. 53,156 50,218
Accumulated deficit .................................................... (241,528) (243,075)
--------- ---------
Total stockholder's deficit .................................... (188,372) (192,857)
--------- ---------
Total liabilities and stockholder's equity (deficit) ........... $ 66,322 $ 68,475
========= =========
The accompanying notes are an integral
part of these financial statements.
4
5
LIGGETT GROUP INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(Dollars in thousands)
Three Months Ended Six Months Ended
June 30, June 30,
--------------------------- ---------------------------
1998 1997 1998 1997
------------ ----------- ----------- -----------
Net sales* ........................................... $ 83,398 $ 78,142 $ 149,024 $ 144,443
Cost of sales* ........................................ 33,082 36,214 59,270 66,473
--------- --------- --------- ---------
Gross profit ................................ 50,316 41,928 89,754 77,970
Selling, general and administrative expenses .......... 40,022 37,430 72,728 71,353
Settlement charges .................................... 1,399 -- 1,881 --
Restructuring ......................................... -- 70 -- 1,831
--------- --------- --------- ---------
Operating income ............................ 8,895 4,428 15,145 4,786
Other income (expense):
Interest income .................................. -- 3 -- 60
Interest expense ................................. (7,352) (5,930) (14,434) (11,970)
Equity in income of affiliate .................... -- 218 -- 185
Sale of assets ................................... 468 2,402 836 3,994
Retirement of debt ............................... -- -- -- 2,963
Miscellaneous, net ............................... -- 1 -- --
--------- --------- --------- ---------
Net income .................................. $ 2,011 $ 1,122 $ 1,547 $ 18
========= ========= ========= =========
*Net sales and cost of sales include federal excise taxes of $17,666, $19,153,
$32,476, and $36,013, respectively.
The accompanying notes are an integral
part of these financial statements.
5
6
LIGGETT GROUP INC.
CONSOLIDATED STATEMENT OF STOCKHOLDER'S EQUITY (DEFICIT)
(Unaudited)
(Dollars in thousands)
Common
Stock and Total
Contributed Accumulated Stockholder's
Capital Deficit Deficit
------------- ------------ -------------
Balance at December 31, 1997 ..................... $ 50,218 $(243,075) $(192,857)
Net income ..................................... -- 1,547 1,547
Effectiveness fee on debt ...................... 4,105 -- 4,105
Transfer of ownership interest in an affiliate . (1,167) -- (1,167)
--------- --------- ---------
Balance at June 30, 1998 .......................... $ 53,156 $(241,528) $(188,372)
========= ========= =========
The accompanying notes are an integral
part of these financial statements.
6
7
LIGGETT GROUP INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(Dollars in thousands)
Six Months Ended
June 30,
-------------------------
1998 1997
--------- ---------
Cash flows from operating activities:
Net income ......................................................... $ 1,547 $ 18
Adjustments to reconcile net income to net cash used in operating
activities:
Depreciation and amortization ................................... 3,400 3,482
Gain on sale of property, plant and equipment ................... (836) (3,994)
Gain on retirement of notes ..................................... -- (2,963)
Effectiveness fee on debt ....................................... 1,710 --
Deferred finance charges and debt discount written off .......... -- 130
Equity in income of affiliate ................................... -- (185)
Changes in assets and liabilities:
Accounts receivable ............................................. (2,050) 7,430
Inventories ..................................................... 3,508 7,197
Accounts payable ................................................ (1,764) (2,364)
Accrued expenses ................................................ (5,166) (8,607)
Non-current employee benefits ................................... (52) (205)
Other, net ...................................................... 1,916 (974)
--------- ---------
Net cash provided by (used in) operating activities ....... 2,213 (1,035)
Cash flows from investing activities:
Proceeds from sale of property, plant and equipment ................ 1,171 4,743
Capital expenditures ............................................... (694) (1,086)
Purchase of an option in affiliate ................................. -- (2,200)
--------- ---------
Net cash provided by investing activities .................. 477 1,457
Cash flows from financing activities:
Repayments of long-term debt ....................................... (28) (4,664)
Borrowings under revolving credit facility ......................... 124,042 137,062
Repayments under revolving credit facility ......................... (124,792) (132,308)
Deferred finance charges ........................................... (439) --
Decrease in cash overdraft ......................................... (891) (6)
--------- ---------
Net cash (used in) provided by financing activities ........ (2,108) 84
Net increase in cash and cash equivalents .............................. 582 506
Cash and cash equivalents:
Beginning of period ................................................ -- --
--------- ---------
End of period ...................................................... $ 582 $ 506
Supplemental cash flow information: Cash payments during the period for:
Interest ....................................................... $ 11,064 $ 11,984
Income taxes ................................................... $ 126 $ 108
The accompanying notes are an integral
part of these financial statements.
7
8
LIGGETT GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
(Dollars in thousands, except per share amounts)
1. THE COMPANY
Liggett Group Inc. ("Liggett" or the "Company") is a wholly-owned
subsidiary of BGLS Inc. ("BGLS"), a wholly-owned subsidiary of Brooke Group Ltd.
("BGL"). Liggett is engaged primarily in the manufacture and sale of cigarettes,
principally in the United States. Certain management and administrative
functions are performed by affiliates. (See Note 9.)
The consolidated financial statements included herein are unaudited
and, in the opinion of management, reflect all adjustments necessary (which are
normal and recurring) to present fairly the Company's consolidated financial
position, results of operations and cash flows. The December 31, 1997 balance
sheet has been derived from audited financial statements. These consolidated
financial statements should be read in conjunction with the consolidated
financial statements included in the Company's Annual Report on Form 10-K, as
amended, for the year ended December 31, 1997, as filed with the Securities and
Exchange Commission. The results of operations for interim periods should not be
regarded as necessarily indicative of the results that may be expected for the
entire year.
The accompanying consolidated financial statements have been prepared
assuming that the Company will continue as a going concern. Liggett had a net
capital deficiency of $188,372 as of June 30, 1998, is highly leveraged and has
substantial near-term debt service requirements. (See Note 7.) Due to the many
risks and uncertainties associated with the cigarette industry and the impact of
tobacco litigation (see Note 8), there can be no assurance that the Company will
be able to meet its future earnings or cash flow goals. Consequently, the
Company could be in violation of its debt covenants, including covenants
limiting the maximum permitted net worth and working capital deficiencies, and
if its lenders were to exercise acceleration rights under its revolving credit
facility (the "Facility") or the indenture for its Senior Secured Notes (the
"Liggett Notes") or refuse to lend under the Facility, the Company would not be
able to satisfy such demands or its working capital requirements.
The Liggett Notes mature on February 1, 1999 and the Facility expires
on March 9, 1999. Accordingly, as of June 30, 1998, the current maturities of
the Liggett Notes of $144,780 (net of unamortized discount) and of the Facility
of $22,678 contribute substantially to the working capital deficit of $176,784.
On January 30, 1998, the Company obtained the consents of the required
majority of the holders of the Liggett Notes to various amendments to the
Indenture governing the Liggett Notes. The amendments provided, among other
things, for a deferral of the February 1, 1998 mandatory redemption of $37,500
principal amount of the Liggett Notes to the date of final maturity, February 1,
1999. (Refer to Note 7.) At maturity, the Liggett Notes will require a principal
payment of $144,891. The Company does not anticipate it will be able to generate
sufficient cash from operations to make such payments. In addition, the Company
has a $40,000 Facility expiring March 8, 1999 under which $22,678 was
outstanding at June 30, 1998. While management currently intends to seek to
refinance and/or restructure with the Company's note holders the maturity
requirements on the Liggett Notes and to extend the Facility, there are no
refinancing or restructuring arrangements for the notes or commitments to extend
the Facility at this time, and no assurances can be given in this regard. If the
Company is unable to refinance or restructure the terms of the Liggett Notes or
otherwise make all payments thereon, the Liggett Notes and the Facility would be
in default and holders of such debt could accelerate the maturity of such debt.
In such event, Liggett may be forced to seek protection from creditors under
applicable laws. These matters
8
9
raise substantial doubt about the Company meeting its liquidity needs and its
ability to continue as a going concern. The financial statements do not include
any adjustments that might result from the outcome of this uncertainty.
The Company adopted Statement of Financial Accounting Standards No.
130, "Reporting Comprehensive Income" ("SFAS No. 130"), for the year ending
December 31, 1998. SFAS No. 130 requires the Company to display an amount
representing the total comprehensive income for the period in a financial
statement which is displayed with the same prominence as other financial
statements. The Company has no items of other comprehensive income in any period
presented and therefore is not required to report comprehensive income.
The Company will adopt Statement of Financial Accounting Standards No.
131, "Disclosures about Segments of an Enterprise and Related Information"
("SFAS No. 131"), for the year ending December 31, 1998. SFAS No. 131 requires
the Company to report certain information about operating segments in complete
sets of financial statements and in condensed financial statements of interim
period issued to shareholders. It also establishes standards for related
disclosures about products and services, geographic areas and major customers.
The Company does not expect this new pronouncement to have a significant impact
on the financial statements.
The Company will adopt Statement of Financial Accounting Standards No.
132, "Employers' Disclosures about Pensions and Other Postretirement Benefits"
("SFAS No. 132"), for the year ending December 31, 1998. SFAS No. 132
standardizes the disclosure requirements for pensions and other postretirement
benefits to the extent practicable, requires additional information and changes
in the benefit obligations and fair values of plan assets that will facilitate
financial analysis, and eliminates certain disclosures that are no longer
useful. The Company has not yet determined the impact of this pronouncement.
2. ESTIMATES AND ASSUMPTIONS
The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities, the
disclosure of contingent assets and liabilities and the reported amounts of
revenues and expenses. Significant estimates subject to material changes in the
near term include allowance for doubtful accounts, sales returns and allowances,
actuarial assumptions of pension plans and litigation and defense costs. Actual
results could differ from those estimates.
3. PER SHARE DATA
All of the Company's common shares (1,000 shares, issued and
outstanding for all periods presented herein) are owned by BGLS. Accordingly,
earnings and dividends per share data are not presented in these consolidated
financial statements.
4. SALE OF ASSETS
On March 11, 1997, Liggett sold to Blue Devil Ventures, a North
Carolina limited liability partnership, certain surplus realty in Durham, North
Carolina, for a sale price of $2,200. A gain of $1,147 was recognized, net of
costs required to prepare the properties for sale and selling costs. (See Note 9
for sales to affiliates.)
9
10
5. INVENTORIES
Inventories consist of the following:
June 30, December 31,
1998 1997
-------- ------------
Finished goods ............... $ 12,456 $ 13,273
Work-in-process .............. 2,256 1,926
Raw materials ................ 16,693 21,211
Replacement parts and supplies 3,465 3,545
-------- --------
Inventories at current cost .. 34,870 39,955
LIFO adjustment .............. (3,321) (4,898)
-------- --------
Inventories at LIFO cost ..... $ 31,549 $ 35,057
======== ========
The Company has a leaf inventory management program whereby, among
other things, it is committed to purchase certain quantities of leaf tobacco.
The purchase commitments are for quantities not in excess of anticipated
requirements and are at prices, including carrying costs, established at the
date of the commitment. Liggett had leaf tobacco purchase commitments of
approximately $7,311 at June 30, 1998.
6. PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment consists of the following:
June 30, December 31,
1998 1997
-------- --------
Land and improvements ............................... $ 411 $ 411
Buildings ........................................... 6,015 6,228
Machinery and equipment ............................. 39,949 40,569
-------- --------
Property, plant and equipment ....................... 46,375 47,208
Less accumulated depreciation ....................... (29,702) (29,452)
-------- --------
Property, plant and equipment, net .................. $ 16,673 $ 17,756
======== ========
10
11
7. LONG-TERM DEBT
Long-term debt consists of the following:
June 30, December 31,
1998 1997
--------- ----------
11.5% Senior Secured Notes due February 1, 1999,
net of unamortized discount of $111 and $206,
respectively ..................................... $ 112,501 $ 112,406
Variable Rate Series C Senior Secured Notes due
February 1, 1999 ................................. 32,279 32,279
Borrowings outstanding under revolving credit
facility ......................................... 22,678 23,427
Other ............................................... -- 28
--------- ---------
167,458 168,140
Current portion ..................................... (167,569) (28)
Unamortized discount, current portion ............... 111 --
--------- ---------
Amount due after one year ........................... $ -- $ 168,112
========= =========
SENIOR SECURED NOTES
On February 14, 1992, Liggett issued $150,000 in Senior Secured Notes
(the "Series B Notes"). Interest on the Series B Notes is payable semiannually
on February 1 and August 1 at an annual rate of 11.5%. The Series B Notes and
Series C Notes referred to below (collectively, the "Liggett Notes") required
mandatory principal redemptions of $7,500 on February 1 in each of the years
1993 through 1997 and $37,500 on February 1, 1998 with the balance of the
Liggett Notes due on February 1, 1999. In February 1997, $7,500 of the Series B
Notes were purchased using revolver availability and credited against the
mandatory redemption requirements. The transaction resulted in a net gain of
$2,963. The Liggett Notes are collateralized by substantially all of the assets
of the Company, excluding inventories and receivables. Eve is a guarantor for
the Notes. The Liggett Notes may be redeemed, in whole or in part, at a price
equal to 100% of the principal amount at the option of the Company. The Liggett
Notes contain restrictions on Liggett's ability to declare or pay cash
dividends, incur additional debt, grant liens and enter into any new agreements
with affiliates, among others.
The Series C Notes, issued in 1994, have the same terms (other than
interest rate) and stated maturity as the Series B Notes. The Series C Notes
bore a 16.5% interest rate, which was reset on February 1, 1995 to 19.75%.
On January 30, 1998, with the consent of the required majority of the
holders of the Liggett Notes, Liggett entered into various amendments to the
Indenture governing the Liggett Notes, which provided, among other things, for a
deferral of the February 1, 1998 mandatory redemption payment of $37,500 to the
date of final maturity of the Liggett Notes on February 1, 1999. In connection
with the deferral, BGL agreed to issue 483,002 shares of BGL's common stock to
the holders of record on January 15, 1998 of the Liggett Notes. As a result of
this transaction, the Company recorded a deferred charge of approximately $4,100
during the first quarter of 1998 reflecting the fair value of the instruments
issued. This deferred charge is being amortized as an adjustment to interest
expense over a period of one year. The Indenture under which the Liggett Notes
are outstanding was also amended to prohibit, with limited exceptions, payments
of dividends and incurrence of new debt by Liggett and to tighten restrictions
on the disposition of proceeds of asset sales. BGL and BGLS also agreed to
guarantee the payment by Liggett of the August 1, 1998 interest payment on the
Liggett Notes and to subordinate, until repayment in full of all amounts
11
12
outstanding in respect of the Liggett Notes, their reimbursement rights with
respect to the guarantee of borrowings under the Facility made in connection
with the Company's August 1, 1997 interest installment and any future advances
in connection with the guarantee of the August 1, 1998 interest payment. In
consideration of the contribution of the BGL common stock, the waiver of certain
management and other fees, the guarantee of the interest payments and
subordination of certain reimbursement rights, the Company transferred its
ownership interest in, and options to acquire additional shares of stock of,
Liggett-Ducat Ltd. ("Liggett-Ducat") to Brooke (Overseas) Ltd. ("BOL"), a
subsidiary of BGLS. The Company accounted for the transfer of its ownership
interest in, and options to acquire additional shares of stock of, Liggett-Ducat
to BOL as a capital distribution to BGLS. Based on the carrying value of the
investment at January 30, 1998, the capital distribution is approximately
$1,167. In addition, the Liggett Noteholders were granted additional collateral
in the form of a security interest in 16% of the stock of Liggett-Ducat or a
successor entity held by BOL.
On February 1, 1999, all of the Liggett Notes, totaling $144,891, will
reach maturity. There are no refinancing or restructuring arrangements in place
at this time for the notes and no assurances can be given in this regard. (Refer
to Note 1.)
REVOLVING CREDIT FACILITY
On March 8, 1994, Liggett entered into the Facility under which it can
borrow up to $40,000 (depending on the amount of eligible inventory and
receivables as determined by the lenders) from a syndicate of commercial
lenders. Availability under the Facility was approximately $5,946 based upon
eligible collateral at June 30, 1998. The Facility is collateralized by all
inventories and receivables of the Company. Borrowings under the Facility are
charged interest calculated at a rate equal to 1.5% above Philadelphia National
Bank's (the indirect parent of Congress Financial Corporation, the lead lender)
prime rate. Liggett's interest rate is currently 10.0%. The Facility contains
certain financial covenants similar to those contained in the Liggett Notes
Indenture, including restrictions on Liggett's ability to declare or pay cash
dividends, incur additional debt, grant liens and enter into any new agreements
with affiliates, among others. In addition, the Facility, as amended April 8,
1998, imposes requirements with respect to the Company's adjusted net worth (not
to fall below a deficit of $195,000 as computed in accordance with the
agreement, this computation was $185,051 at June 30, 1998) and working capital
(not to fall below a deficit of $17,000 as computed in accordance with the
agreement, this computation was $6,005 at June 30, 1998). The Facility, as
amended, also provides that a default by Liggett or its subsidiaries under the
March 1996 Settlements, March 1997 Settlements and March 1998 Settlements (all
as defined below in Note 8) shall constitute an event of default under the
Facility.
In November 1997, the Facility was extended until March 8, 1999. For
information concerning Liggett's substantial near-term debt service requirements
and other related matters, see Note 1.
8. COMMITMENTS AND CONTINGENCIES
TOBACCO-RELATED LITIGATION:
OVERVIEW. Since 1954, Liggett and other United States cigarette
manufacturers have been named as defendants in numerous direct and third-party
actions predicated on the theory that cigarette manufacturers should be liable
for damages from cancer and other adverse health effects alleged to have been
caused by cigarette smoking or by exposure to secondary smoke (environmental
tobacco smoke, "ETS") from cigarettes. These cases are reported hereinafter as
though having been commenced against Liggett (without regard to whether such
cases were actually commenced against Liggett or BGL). There has been a
noteworthy increase in the number of cases commenced against Liggett and the
other cigarette manufacturers. The cases generally fall into four categories:
(i) smoking and health cases alleging personal injury brought on behalf of
individual smokers ("Individual Actions"), (ii) smoking and health cases
12
13
alleging personal injury and purporting to be brought on behalf of a class
of plaintiffs ("Class Actions"), (iii) health care cost recovery actions brought
by state and local governments ("Attorneys General Actions") and (iv) health
care cost recovery actions brought by third-party payors including asbestos
manufacturers, unions and taxpayers ("Third-Party Payor Actions"). As new cases
are commenced, defense costs and the risks attendant to the inherent
unpredictability of litigation continue to increase. Liggett had been receiving
assistance from others in the industry in defraying the costs and other burdens
incurred in the defense of smoking and health litigation and related
proceedings, which, for the most part, consisted of the payment of counsel fees
and costs, but this assistance terminated in 1997. The future financial impact
on Liggett of the termination of this assistance and the effects of the tobacco
litigation settlements discussed below is not quantifiable at this time. For the
six months ended June 30, 1998, Liggett incurred counsel fees and costs totaling
approximately $2,562, compared to $2,152 for the comparable prior year period.
In June 1992, in an action entitled CIPOLLONE V. LIGGETT GROUP INC., ET
AL., the United States Supreme Court issued an opinion concluding that The
Federal Cigarette Labeling and Advertising Act did not preempt state common law
damage claims but that The Public Health Cigarette Smoking Act of 1969 (the
"1969 Act") did preempt certain, but not all, state common law damage claims.
The decision bars plaintiffs from asserting claims that, after the effective
date of the 1969 Act, the tobacco companies either failed to warn adequately of
the claimed health risks of cigarette smoking or sought to neutralize those
claimed risks in their advertising or promotion of cigarettes. Bills have been
introduced in Congress on occasion to eliminate the federal preemption defense.
Enactment of any federal legislation with such an effect could result in a
significant increase in claims, liabilities and litigation costs.
INDIVIDUAL ACTIONS. As of June 30, 1998, there were approximately 245
cases pending against Liggett, and in most cases the other tobacco companies,
where individual plaintiffs allege injury resulting from cigarette smoking,
addiction to cigarette smoking or exposure to ETS and seek compensatory and, in
some cases, punitive damages. Of these, 95 were pending in the State of Florida,
84 in the State of New York and 20 in the State of Texas. The balance of
individual cases were pending in 16 states. There are three individual cases
pending where Liggett is the only named defendant.
The plaintiffs' allegations of liability in those cases in which
individuals seek recovery for personal injuries allegedly caused by cigarette
smoking are based on various theories of recovery, including negligence, gross
negligence, special duty, voluntary undertaking, strict liability, fraud,
misrepresentation, design defect, failure to warn, breach of express and implied
warranties, conspiracy, aiding and abetting, concert of action, unjust
enrichment, common law public nuisance, indemnity, market share liability, and
violations of deceptive trade practices laws, the Federal Racketeer Influenced
and Corrupt Organization Act ("RICO") and antitrust statutes. In many of these
cases, in addition to compensatory damages, plaintiffs also seek other forms of
relief including disgorgement of profits and punitive damages. Defenses raised
by defendants in these cases include lack of proximate cause, assumption of the
risk, comparative fault and/or contributory negligence, lack of design defect,
statute of limitations, equitable defenses such as "unclean hands" and lack of
benefit, failure to state a claim and federal preemption.
On May 12, 1998, Liggett settled an individual tobacco-related action
entitled WIDDICK V. BROWN & WILLIAMSON, Duval County Circuit Court, Florida. The
settlement will not have a material affect on Liggett's or BGL's financial
condition, results of operations or cash flows.
CLASS ACTIONS. As of June 30, 1998, there were approximately 40 actions
pending, for which either a class has been certified or plaintiffs are seeking
class certification, where Liggett, among others, was a named defendant. Two of
these cases, FLETCHER, ET AL. V. BROOKE GROUP LTD., ET AL. and WALKER, ET AL. V.
LIGGETT GROUP INC., ET AL. have been settled by Liggett, subject to court
approval. These two settlements are more fully discussed below under the
"Settlements" section.
13
14
In October 1991, an action entitled BROIN, ET AL. V. PHILIP MORRIS
INCORPORATED, ET AL., Circuit Court of the Eleventh Judicial District in and for
Dade County, Florida, was filed against Liggett and others. This case was
brought by plaintiffs on behalf of all flight attendants that worked or are
presently working for airlines based in the United States and who never
regularly smoked cigarettes but allege that they have been damaged by
involuntary exposure to ETS. In October 1997, the other major tobacco companies
settled this matter which settlement provides for a release of Liggett and BGL.
In February 1998, the Circuit Court approved the settlement; however, an
objector filed a Notice of Appeal of the settlement in the Third District Court
of Appeal.
In March 1994, an action entitled CASTANO, ET AL. V. THE AMERICAN
TOBACCO COMPANY INC., ET AL., United States District Court, Eastern District of
Louisiana, was filed against Liggett and others. The class action complaint
sought relief for a nationwide class of smokers based on their alleged addiction
to nicotine. In February 1995, the District Court granted plaintiffs' motion for
class certification (the "Class Certification Order").
In May 1996, the Court of Appeals for the Fifth Circuit reversed the
Class Certification Order and instructed the District Court to dismiss the class
complaint. The Fifth Circuit ruled that the District Court erred in its analysis
of the class certification issues by failing to consider how variations in state
law affect predominance of common questions and the superiority of the class
action mechanism. The appeals panel also held that the District Court's
predominance inquiry did not include consideration of how a trial on the merits
in CASTANO would be conducted. The Fifth Circuit further ruled that the
"addiction-as-injury" tort is immature and, accordingly, the District Court
could not know whether common issues would be a "significant" portion of the
individual trials. According to the Fifth Circuit, any savings in judicial
resources that class certification may bring about is speculative and would
likely be overwhelmed by the procedural problems certification brings. Finally,
the Fifth Circuit held that in order to make the class action manageable, the
District Court would be forced to bifurcate issues in violation of the Seventh
Amendment.
The extent of the impact of the CASTANO decision on tobacco-related
class action litigation is still uncertain, although the decertification of the
CASTANO class by the Fifth Circuit may preclude any federal court from
certifying a nationwide class action for trial purposes with respect to
tobacco-related claims. The CASTANO decision has had, however, only limited
effect with respect to courts' decisions regarding narrower tobacco-related
classes or class actions brought in state rather than federal court. For
example, since the Fifth Circuit's ruling, courts in New York, Louisiana and
Maryland have certified "addiction-as-injury" class actions that covered only
citizens in those states. Two class actions pending in state court in Florida
have also been certified, one of which, the BROIN case, was settled in 1997. The
CASTANO decision has had no measurable impact on litigation brought by or on
behalf of single individual claimants.
ATTORNEY GENERAL ACTIONS. As of June 30, 1998, 40 Attorney General
Actions were filed against Liggett and BGL. As more fully discussed below,
Liggett and BGL have settled 36 of these actions. In addition, Liggett has
reached settlements with nine Attorneys General representing states,
commonwealths or territories that have not yet commenced litigation against
Liggett or BGL. In these proceedings, state and local government entities seek
reimbursement for Medicaid and other health care expenditures allegedly caused
by use of tobacco products. The claims asserted in these health care cost
recovery actions vary. In most of these cases, plaintiffs assert the equitable
claim that the tobacco industry was "unjustly enriched" by plaintiffs' payment
of health care costs allegedly attributable to smoking and seek reimbursement of
those costs. Other claims made by some but not all plaintiffs include the
equitable claim of indemnity, common law claims of negligence, strict liability,
breach of express and implied warranty, violation of a voluntary undertaking or
special duty, fraud, negligent misrepresentation, conspiracy, public nuisance,
claims under state and federal statutes governing consumer fraud, antitrust,
deceptive trade practices and false advertising, and claims under RICO.
14
15
THIRD-PARTY PAYOR ACTIONS. As of June 30, 1998, there were
approximately 55 Third-Party Payor Actions pending. The claims in these cases
are similar to those in the Attorney General Actions. In April 1998, a group
known as the "Coalition for Tobacco Responsibility", which represents Blue Cross
and Blue Shield Plans in more than 35 states, filed federal lawsuits against the
industry seeking payment of health-care costs allegedly incurred as a result of
cigarette smoking and ETS. The lawsuits were filed in Federal District Courts in
New York, Chicago and Seattle and seek billions of dollars in damages. The
lawsuits allege conspiracy, fraud, misrepresentation, and violation of federal
racketeering and anti-trust laws as well as other claims.
SETTLEMENTS. In March, 1996, Liggett and BGL entered into an agreement,
subject to court approval, to settle the CASTANO class action tobacco
litigation. Under the CASTANO settlement agreement, upon final court approval of
the settlement, the CASTANO class would be entitled to receive up to five
percent of Liggett's pretax income (income before income taxes) each year (up to
a maximum of $50,000 per year) for the next 25 years, subject to certain
reductions provided for in the agreement and a $5,000 payment from Liggett if
Liggett or BGL fail to consummate a merger or similar transaction with another
non-settling tobacco company defendant within three years of the date of
settlement. Liggett and BGL have the right to terminate the CASTANO settlement
under certain circumstances. On March 14, 1996, Liggett, the CASTANO Plaintiffs
Legal Committee and the CASTANO plaintiffs entered into a letter agreement.
According to the terms of the letter agreement, for the period ending nine
months from the date of Final Approval (as defined in the letter), if granted,
of the CASTANO settlement or, if earlier, the completion by Liggett or BGL of a
combination with any defendant in CASTANO, except Philip Morris, the CASTANO
plaintiffs and their counsel agree not to enter into any more favorable
settlement agreement with any CASTANO defendant which would reduce the terms of
the CASTANO settlement agreement. If the CASTANO plaintiffs or their counsel
enter into any such settlement during this period, they shall pay Liggett
$250,000 within 30 days of the more favorable agreement and offer Liggett and
BGL the option to enter into a settlement on terms at least as favorable as
those included in such other settlement. The letter agreement further provides
that during the same time period, and if the CASTANO settlement agreement has
not been earlier terminated by Liggett in accordance with its terms, Liggett and
its affiliates will not enter into any business transaction with any third party
which would cause the termination of the CASTANO settlement agreement. If
Liggett or its affiliates enter into any such transaction, then the CASTANO
plaintiffs will be entitled to receive $250,000 within 30 days from the
transacting party. In May 1996, the CASTANO Plaintiffs Legal Committee filed a
motion with the United States District Court for the Eastern District of
Louisiana seeking preliminary approval of the CASTANO settlement. In September
1996, shortly after the class was decertified, the CASTANO plaintiffs withdrew
the motion for approval of the CASTANO settlement.
In March 1996, Liggett and BGL entered into a settlement of
tobacco-related litigation with the Attorneys General of Florida, Louisiana,
Massachusetts, Mississippi and West Virginia (the "March 1996 Settlements"). The
March 1996 Settlements release Liggett and BGL from all tobacco-related claims
including claims for health case cost reimbursement and claims concerning sales
of cigarettes to minors. Certain of the terms of the March 1996 Settlements are
summarized below.
Under the March 1996 Settlements, the five settling states would share
an initial payment by Liggett of $5,000, payable over nine years and indexed and
adjusted for inflation, provided that any unpaid amount will be due 60 days
after either a default by Liggett in its payment obligations under the
settlement or a merger or other similar transaction by Liggett or BGL with
another defendant in the lawsuits. In addition, Liggett will be required to pay
the settling states a percentage of Liggett's pretax income (income before
income taxes) each year from the second through the twenty-fifth year. This
annual percentage is 2.5% of Liggett's pretax income, subject to increase to
7.5% depending on the number of additional states joining the settlement. No
additional states have joined this settlement to date. All of Liggett's payments
are subject to certain reductions provided for in the agreement. Liggett has
also agreed to pay to the settling states $5,000 if Liggett or BGL fails to
consummate a merger or other similar transaction with another defendant in the
lawsuits within three years from the date of the March 1996 Settlements.
15
16
Settlement funds received by the Attorneys General will be used to
reimburse the states for smoking-related health care costs. Liggett and BGL also
have agreed to phase in compliance with certain of the proposed interim FDA
regulations on the same basis as provided in the CASTANO settlement. Liggett and
BGL have the right to terminate the March 1996 Settlements with respect to any
settling state if any of the remaining defendants in the litigation succeed on
the merits in that state's respective Attorney General action. Liggett and BGL
may also terminate the March 1996 Settlements if they conclude that too many
states have filed Attorney General actions and have not settled such cases with
Liggett and BGL.
In March 1997, Liggett, BGL and the five settling states executed an
addendum pursuant to which Liggett and BGL agreed to provide to the five
settling states, among other things, the additional cooperation and compliance
with advertising restrictions that is provided for in the March 1997 Settlements
(discussed below). Also, pursuant to the addendum, the initial settling states
agreed to use best efforts to ensure that in the event of a global tobacco
settlement enacted through federal legislation or otherwise, Liggett's and BGL's
financial obligations under such a global settlement would be no more onerous
than under this settlement.
During 1997, Liggett and BGL entered into a comprehensive settlement of
tobacco litigation through parallel agreements with the Attorneys General of 21
states and with a nationwide class of individuals and entities that allege
smoking-related claims (settlements with these 21 Attorneys General and with the
nationwide class are hereinafter referred to as the "March 1997 Settlements").
In March 1998, Liggett and BGL announced settlements with the Attorneys General
of 15 states, the District of Columbia, Guam, Northern Mariana Islands and the
U.S. Virgin Islands (the "March 1998 Settlements"). The foregoing settlements
cover all smoking-related claims, including both addiction-based and tobacco
injury claims against Liggett and BGL, brought by the Attorneys General and,
upon court approval, the nationwide class.
The states, commonwealths and territories where settlements have been
reached with Attorneys General are: Alaska, Arizona, Arkansas, California,
Colorado, Connecticut, District of Columbia, Florida, Georgia, Guam, Hawaii,
Idaho, Illinois, Indiana, Iowa, Kansas, Louisiana, Maine, Maryland,
Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska,
Nevada, New Hampshire, New Jersey, New Mexico, New York, North Dakota, Northern
Mariana Islands, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, Texas,
Utah, U.S. Virgin Islands, Washington, West Virginia, Wisconsin and Wyoming.
Other states have either recently filed health care cost recovery actions or
indicated intentions to do so. Both Liggett and BGL will endeavor to resolve
those actions on substantially the same terms and conditions as the March 1998
Settlements, however, there can be no assurance that any such settlements will
be completed.
As mentioned above, in March 1997, Liggett, BGL and plaintiffs filed
the mandatory class settlement agreement in an action entitled FLETCHER, ET AL.
V. BROOKE GROUP LTD., ET AL., Circuit Court of Mobile County, Alabama, where the
court granted preliminary approval and preliminary certification of the class,
and in May 1997, a similar mandatory class settlement agreement was filed in an
action entitled WALKER, ET AL. V. LIGGETT GROUP INC., ET AL., United States
District Court, Southern District of West Virginia. On July 2, 1998, Liggett,
BGL and plaintiffs filed an amended class action settlement agreement in
FLETCHER. Pursuant to the amended agreement, Liggett is required to pay to the
class 7.5% of Liggett's pre-tax income each year for 25 years, with a minimum
annual payment guarantee of $1,000 over the term of the agreement. The amended
agreement does not set forth a formula with respect to the distribution of
settlement proceeds to the class. The Company anticipates that should the court
in FLETCHER, after dissemination of notice to the class of the pending limited
fund class action settlement and a full fairness hearing with respect thereto,
issue a final order and judgment approving the settlement, such an order would
preclude further prosecution by class members of tobacco-related claims against
Liggett and BGL. Under the Full Faith and Credit Act, a final judgment entered
in a nationwide class action pending in a state court has a preclusive effect
against any class member with respect to the claims settled and released in the
nationwide class action. As the class definition in FLETCHER encompasses all
persons in the United States who could claim injury as a result of cigarette
smoking or ETS and any third-party payor claimants, it is
16
17
anticipated that, upon final order and judgment, all such persons and
third-party payor claimants would be barred from further prosecution of
tobacco-related claims against Liggett and BGL.
In the FLETCHER action, it is anticipated that class members will be
notified of the settlement and will have an opportunity to appear at a later
court hearing. Effectiveness of the mandatory settlement is conditioned on final
court approval of the settlement after a fairness hearing. There can be no
assurance as to whether, or when, such court approval will be obtained.
The WALKER court also granted preliminary approval and preliminary
certification of the nationwide class; however, on August 5, 1997, the court
vacated its preliminary certification of the settlement class, which decision is
currently on appeal. The WALKER court relied on the Supreme Court's decision in
AMCHEM PRODUCTS INC. V. WINDSOR in reaching its decision. In AMCHEM, the Supreme
Court affirmed a decision of the Third Circuit vacating the certification of a
settlement class that involved asbestos-exposure claims. The Supreme Court held
that the proposed settlement class did not meet the requirements for Rule 23 of
the Federal Rules of Civil Procedure for predominance of common issues and
adequacy of representation. The Third Circuit had held that, although classes
could be certified for settlement purposes only, Rule 23's requirements had to
be satisfied as if the case were going to be litigated. The Supreme Court agreed
that the fairness and adequacy of the settlement are not pertinent to the
predominance inquiry under Rule 23(b)(3), and thus, the proposed class must have
sufficient unity so that absent class members can fairly be bound by decisions
of class representatives.
After the AMCHEM opinion was issued by the Supreme Court on June 25,
1997, objectors to Liggett's settlement in WALKER moved for decertification.
Although Liggett's settlements, particularly in the WALKER action, are "limited
fund" class action settlements proceeding under Rule 23(b)(1), and AMCHEM was a
Rule 23(b)(3) case, the court in the WALKER action, nonetheless, decertified the
WALKER class. Applying AMCHEM to the WALKER case, the District Court, in a
decision issued on August 5, 1997, determined that while plaintiffs in WALKER
have a common interest in "maximizing the limited fund available from the
defendants," there remained "substantial conflicts among class members relating
to distribution of the fund and other key concerns" that made class
certification inappropriate.
The AMCHEM decision's ultimate effect on the viability of the WALKER
and FLETCHER settlements remains uncertain given the Fifth Circuit's recent
ruling reaffirming the limited fund class action settlement in IN RE ASBESTOS
LITIGATION ("AHEARN"). In June 1997, the Supreme Court remanded AHEARN to the
Fifth Circuit for consideration in light of AMCHEM. On remand, the Fifth Circuit
made two decisive distinctions between AMCHEM and AHEARN. First, the AHEARN
class action proceeded under Rule 23(b)(1) while AMCHEM was a Rule 23(b)(3) case
and second, in AHEARN, there was no allocation or difference in award, according
to nature or severity of injury, as there was in AMCHEM. The Fifth Circuit
concluded that all members of the class and all class representatives share
common interests and none of the uncommon questions abounding in AMCHEM exist.
On June 22, 1998, the Supreme Court granted certiorari to review the Fifth
Circuit decision.
The remaining material terms of the March 1996 Settlements, the March
1997 Settlements and the March 1998 Settlements are described below.
Pursuant to each of the settlements, both Liggett and BGL agreed to
cooperate fully with the Attorneys General and the nationwide class in their
respective lawsuits against the tobacco industry. Liggett and BGL agreed to
provide to these parties all relevant tobacco documents in their possession,
other than those subject to claims of joint defense privilege, and to waive,
subject to court order, certain attorney-client privileges and work product
protections regarding Liggett's smoking-related documents to the extent Liggett
and BGL can so waive these privileges and protections. The Attorneys General and
the nationwide class agreed to keep Liggett's documents under protective order
and, subject to final court approval, to limit their use to those actions
brought by parties to the settlement agreements. Those documents that may be
subject to a joint defense privilege with other tobacco companies will not be
produced to the Attorneys General or the nationwide class, but will be, pursuant
to court order, submitted
17
18
to the appropriate court and placed under seal for possible IN CAMERA review.
Additionally, under similar protective conditions, Liggett and BGL agreed to
offer their employees for witness interviews and testimony at deposition and
trial. Pursuant to both settlement agreements, Liggett also agreed to place an
additional warning on its cigarette packaging stating that "Smoking is
Addictive" and to issue a public statement, as requested by the Attorneys
General. Liggett has commenced distribution of cigarette packaging which
displays the new warning label.
Pursuant to the March 1996 Settlements, any other tobacco company
defendant, except Philip Morris, merging or combining with Liggett or BGL, prior
to the third anniversary of the settlement, would receive certain settlement
benefits, including limitations on potential liability. Pursuant to the
agreement, any such combining tobacco company would be released from the
lawsuits brought by the five initial settling states. Such combining tobacco
company would be obligated to pay into the settlement fund within sixty days of
becoming bound to the agreement $135,000, and make annual payments of 2.5% of
the combining company's pre-tax income (but not less than $30,000 per year).
Such combining tobacco company would also have to comply with the advertising
and access restrictions provided for in the agreement, and would have to
withdraw their objections to the FDA rule.
Pursuant to the March 1997 Settlements, any other tobacco company
defendant, except Philip Morris, merging or combining with Liggett or BGL, prior
to the fourth anniversary of the settlements, would receive certain settlement
benefits, including limitations on potential liability for affiliates not
engaged in domestic tobacco operations and a waiver of any obligation to post a
bond to appeal any future adverse judgment. In addition, within 120 days
following any such combination, Liggett would be required to pay the settlement
fund $25,000. Under all settlements, the plaintiffs have agreed not to seek an
injunction preventing a defendant tobacco company combining with Liggett or BGL
from spinning off any affiliate which is not engaged in the domestic tobacco
business.
Pursuant to the March 1998 Settlements, Liggett is required to pay each
of settling states and territories their relative share (based on the Medicaid
population of each state over the total Medicaid population of the United
States) of between 27.5% and 30% of Liggett's pre-tax income each year for 25
years, with a minimum payment guarantee of $1,000 per state over the first nine
years of the agreement. The liability was computed using a discount rate of 18%.
The aggregate payments required under the March 1996, March 1997 and March 1998
Settlements are $45,000. Of this amount, $3,389 has been paid as of June 30,
1998. The annual percentage is subject to increase, pro rata from 27.5% - 30%,
depending on the number of additional states joining the settlement. Pursuant to
the "most favored nation" provisions under the March 1996 and March 1997
Settlements, each of the states settling under those settlements could benefit
from the economic terms of the March 1998 Settlements. In all settlements,
Liggett agreed to phase-in compliance with certain proposed FDA regulations
regarding smoking by children and adolescents, including a prohibition on the
use of cartoon characters in tobacco advertising and limitations on the use of
promotional materials and distribution of sample packages where minors are
present. The March 1998 Settlements provide for additional restrictions and
regulations on Liggett's advertising, including a prohibition on outdoor
advertising and product advertising on the Internet and on payments for product
placement in movies and television.
Under all settlements, Liggett and BGL are also entitled to "most
favored nation" treatment in the event any settling Attorney General reaches a
settlement with any other defendant tobacco company. Pursuant to the March 1996
and March 1997 Settlements, in the event of a global settlement involving
federal legislation with any other defendant tobacco company, the settling
Attorneys General agreed to use their "best efforts" to ensure that Liggett's
and BGL's liability under such legislation should be no more onerous than under
those settlements. Under the March 1998 Settlements, the settling Attorneys
General agreed to write letters to Congress and the President of the United
States to ensure that Liggett's and BGL's liability under any such legislation
should be more onerous than under this settlement.
18
19
Liggett accrued approximately $4,000 for the present value of the fixed
payments under the March 1996 Settlements and $16,902 for the present value of
the fixed payments under the March 1998 Settlements. No additional amounts have
been accrued because Liggett cannot quantify the future costs of the settlements
as the amounts Liggett must pay are based, in part, on future operating results.
Possible future payments based on a percentage of pretax income, and other
contingent payments based on the occurrence of a business combination, will be
expensed when considered probable.
Separately, the other tobacco companies negotiated settlements of the
Attorney General Actions in Mississippi, Florida, Texas, and Minnesota, and it
has been widely publicized that the other companies have engaged in negotiations
to settle with the Attorneys General of the remaining states.
Copies of the various settlement agreements are filed as exhibits to
Liggett's Form 10-K and the discussion herein is qualified in its entirety by
reference thereto.
TRIALS. On May 8, 1998, the other tobacco companies settled the
litigation in Minnesota known as the STATE OF MINNESOTA BY HUBERT H. HUMPHREY,
III, ITS ATTORNEY GENERAL AND BLUE CROSS AND BLUE SHIELD OF MINNESOTA V. PHILIP
MORRIS INCORPORATED, ET AL. Liggett settled the claims of the State of Minnesota
on March 20, 1997 and on June 2, 1998 settled the claims of Blue Cross and Blue
Shield of Minnesota. There are several other trial dates scheduled during 1998
for individual cases; however, trial dates are subject to change.
OTHER RELATED MATTERS. In March 1997, RJR, Philip Morris, B&W and
Lorillard obtained a temporary restraining order from a North Carolina state
court preventing Liggett and BGL and their agents, employees, directors,
officers and lawyers from turning over documents allegedly subject to the joint
defense privilege in connection with the settlements, which restraining order
was converted to a preliminary injunction by the court in April 1997. In March
1997, the United States District Court for the Eastern District of Texas and
state courts in Mississippi and Illinois each issued orders enjoining the other
tobacco companies from interfering with Liggett's filing with the courts, under
seal, those documents.
A grand jury investigation is being conducted by the office of the
United States Attorney for the Eastern District of New York (the "Eastern
District Investigation") regarding possible violations of criminal law relating
to the activities of The Council for Tobacco Research - USA, Inc. (the "CTR").
Liggett was a sponsor of the CTR at one time. In May 1996, Liggett received a
subpoena from a Federal grand jury sitting in the Eastern District of New York,
to which Liggett has responded.
In March 1996, and in each of March, July, October and December 1997,
Liggett and/or BGL received subpoenas from a Federal grand jury in connection
with an investigation by the United States Department of Justice (the "DOJ
Investigation") involving the industry's knowledge of the health consequences of
smoking cigarettes; the targeting of children by the industry and the addictive
nature of nicotine and the manipulation of nicotine by the industry. Liggett has
responded to the March 1996, March 1997 and July 1997 subpoenas and is in the
process of responding to the October and December 1997 subpoenas. Liggett
understands that the Eastern District Investigation and the DOJ Investigation
essentially have been consolidated into one investigation conducted by the
Department of Justice (the "DOJ"). Liggett and BGL are unable, at this time, to
predict the outcome of this investigation.
On April 28, 1998, BGL announced that Liggett had reached an agreement
with the United States Department of Justice to cooperate in both the Eastern
District Investigation and the DOJ Investigation. The agreement does not
constitute an admission of any wrongful behavior by Liggett. The DOJ has not
provided immunity to Liggett and has full discretion to act or refrain from
acting with respect to Liggett in the investigation.
Litigation is subject to many uncertainties, and it is possible that
some of the aforementioned actions could be decided unfavorably against Liggett
or BGL. An unfavorable outcome of a pending smoking and health case could
encourage the commencement of additional similar litigation. Liggett is
19
20
unable to evaluate the effect of these developing matters on pending litigation
or the possible commencement of additional litigation. Liggett is also unable to
make a meaningful estimate with respect to the amount of loss that could result
from an unfavorable outcome of many of the cases pending against the Company,
because the complaints filed in these cases rarely detail alleged damages.
Typically, the claims set forth in an individual's complaint against the tobacco
industry pray for money damages in an amount to be determined by a jury, plus
punitive damages and costs. These damage claims are typically stated as being
for the minimum necessary to invoke the jurisdiction of the court.
Third-party payor claimants and others have set forth several
additional variations on relief sought: funding of corrective public education
campaigns relating to issues of smoking and health; funding for clinical smoking
cessation programs; disgorgement of profits from sales of cigarettes;
restitution; treble damages; and attorneys' fees. Nevertheless, no specific
amounts are provided. It is understood that requested damages against the
tobacco company defendants in these cases might be in the billions of dollars.
It is possible that Liggett's consolidated financial position, results
of operation and cash flow could be materially adversely affected by an
unfavorable outcome in any such tobacco-related litigation.
Liggett has been involved in certain environmental proceedings, none of
which, either individually or in the aggregate, rises to the level of
materiality. Liggett's current operations are conducted in material compliance
with all environmental laws and regulations. Management is unaware of any
material environmental conditions affecting its existing facilities. Compliance
with federal, state and local provisions regulating the discharge of materials
into the environment, or otherwise relating to the protection of the
environment, has not had a material effect on the capital expenditures, earnings
or competitive position of Liggett.
There are several other proceedings, lawsuits and claims pending
against Liggett unrelated to smoking or tobacco product liability. Management is
of the opinion that the liabilities, if any, ultimately resulting from such
other proceedings, lawsuits and claims should not materially affect Liggett's
financial position, results of operations or cash flows.
LEGISLATION AND REGULATION:
In January 1993, the United States Environmental Protection Agency
("EPA") released a report on the respiratory effect of ETS which concludes that
ETS is a known human lung carcinogen in adults and in children, causes increased
respiratory tract disease and middle ear disorders and increases the severity
and frequency of asthma. In June 1993, the two largest of the major domestic
cigarette manufacturers, together with other segments of the tobacco and
distribution industries, commenced a lawsuit against the EPA seeking a
determination that the EPA did not have the statutory authority to regulate ETS,
and that given the current body of scientific evidence and the EPA's failure to
follow its own guidelines in making the determination, the EPA's classification
of ETS was arbitrary and capricious. Whatever the outcome of this litigation,
issuance of the report may encourage efforts to limit smoking in public areas.
On July 17, 1998, the court ruled that the EPA made procedural and scientific
mistakes when it declared in its 1993 report that secondhand smoke caused as
many as 3,000 cancer deaths a year among nonsmokers.
In April 1994, the United States Occupational Safety and Health
Administration ("OSHA") issued a proposed rule that could ultimately ban smoking
in the workplace. Hearings were completed during 1995. OSHA has not yet issued a
final rule or a proposed revised rule. While Liggett cannot predict the outcome,
some form of federal regulation of smoking in workplaces may result.
In February 1996, the United States Trade representative issued an
"advance notice of rule making" concerning how tobaccos imported under a
previously established tobacco rate quota ("TRQ") should be allocated.
Currently, tobacco imported under the TRQ is allocated on a "first-come,
first-served" basis, meaning that entry is allowed on an open basis to those
first requesting entry in the quota year.
20
21
Others in the cigarette industry have suggested an "end-user licensing" system
under which the right to import tobacco under the quota would be initially
assigned based on domestic market share. Such an approach, if adopted, could
have a material adverse effect on Liggett.
In August 1996, the FDA filed in the Federal Register a Final Rule (the
"FDA Rule") classifying tobacco as a drug, asserting jurisdiction by the FDA
over the manufacture and marketing of tobacco products and imposing restrictions
on the sale, advertising and promotion of tobacco products. Litigation was
commenced in the United States District Court for the Middle District of North
Carolina challenging the legal authority of the FDA to assert such jurisdiction,
as well as challenging the constitutionality of the rules. The court, after
argument, granted plaintiffs' motion for summary judgment prohibiting the FDA
from regulating or restricting the promotion and advertising of tobacco products
and denied plaintiffs' motion for summary judgment on the issue of whether the
FDA has the authority to regulate access to, and labeling of, tobacco products.
The four major cigarette manufacturers and the FDA have filed notices of appeal.
Liggett and BGL support the FDA Rule and have begun to phase in compliance with
certain of the proposed interim FDA regulations. See discussions of the CASTANO
and Attorney General Actions above.
In August 1996, the Commonwealth of Massachusetts enacted legislation
requiring tobacco companies to publish information regarding the ingredients in
cigarettes and other tobacco products sold in that state. In December 1997, the
United States District Court for the District of Massachusetts enjoined this
legislation from going into effect; however, in December 1997, Liggett began
complying with this legislation by providing ingredient information to the
Massachusetts Department of Public Health.
As part of the budget agreement recently approved by Congress, federal
excise taxes on a pack of cigarettes, which are currently 24 cents, would rise
10 cents in the year 2000 and 5 cents more in the year 2002.
PROPOSED RESOLUTION. In June 1997, Philip Morris Incorporated ("Philip
Morris"), R. J. Reynolds Tobacco Company ("RJR"), B&W, Lorillard Tobacco Company
("Lorillard") and the United States Tobacco Company, along with the Attorneys
General for the States of Arizona, Connecticut, Florida, Mississippi, New York
and Washington and the CASTANO Plaintiffs' Litigation Committee executed a
Memorandum of Understanding to support the adoption of federal legislation and
necessary ancillary undertakings, incorporating the features described in a
proposed resolution (the "Resolution"). The proposed Resolution mandates a total
reformation and restructuring of how tobacco products are manufactured, marketed
and distributed in the United States. (The proposed Resolution is discussed in
Liggett's 1997 Form 10-K/A No. 1.)
In a speech in September 1997, President Clinton called for federal
legislation that, among other things, would raise cigarette prices by up to
$1.50 per pack. Since then, several bills have been introduced in Congress,
including bills modeled after the proposed Resolution, that purport to propose
legislation along these lines. The White House, Congress and various public
interest groups are currently reviewing the proposed Resolution along with other
proposed federal tobacco legislation. Management is unable to predict whether
the proposed Resolution or other federal legislation will be enacted or the form
any such enactment might take. The present legislative and litigation
environment is substantially uncertain and could have a material adverse effect
on the business of Liggett.
In addition to the foregoing, there have been a number of other
restrictive regulatory actions, adverse political decisions and other
unfavorable developments concerning cigarette smoking and the tobacco industry,
the effects of which, at this time, Liggett is not able to evaluate.
21
22
9. RELATED PARTY TRANSACTIONS
On July 5, 1996, Liggett purchased 140,000 shares (19.97%) of
Liggett-Ducat's tobacco operations from BOL, for $2,100. Liggett-Ducat produces
and markets cigarettes in Russia. Liggett also acquired on that date for $3,400
a ten-year option to purchase from BOL at the same per share price up to 292,407
additional shares of Liggett-Ducat, thereby entitling Liggett to increase its
interest in Liggett-Ducat to approximately 62%. On March 13, 1997, Liggett
acquired a second ten-year option to purchase BOL's remaining shares in
Liggett-Ducat (an additional 33%) for $2,200 of which $2,049 was paid in cash,
with the balance settled through intercompany accounts. Such amounts were
accounted for as an element of cash flows from investing activities in the
Company's consolidated statements of cash flows. Liggett accounted for its
investment in Liggett-Ducat under the equity method of accounting. Liggett's
equity in the net income of Liggett-Ducat amounted to $498 for the year ended
December 31, 1997. The excess of the cost of the option over the carrying amount
of net assets to be acquired under the option has been charged to stockholder's
deficit. On January 30, 1998, in connection with the restructuring of the
Liggett Notes, BOL acquired the Liggett-Ducat shares and options held by
Liggett. (Refer to Note 7 to the Company's consolidated financial statements.)
On April 28, 1997, BOL purchased excess production equipment from
Liggett for $3,000. The difference of $2,578 between the sale price and the
carrying value is accounted for as a credit to contributed capital.
Liggett is party to a Tax-Sharing Agreement dated June 29, 1990 with
BGL and certain other entities pursuant to which Liggett has paid taxes to BGL
as if it were filing a separate company tax return, except that the agreement
effectively limits the ability of Liggett to carry back losses for refunds.
Liggett is entitled to recoup overpayments in a given year out of future
payments due under the agreement.
Liggett is a party to an agreement dated February 26, 1991, as amended
October 1, 1995, with BGL to provide various management and administrative
services to the Company in consideration for an annual management fee of $900
paid in monthly installments and annual overhead reimbursements of $864 paid in
quarterly installments.
Liggett has entered into an annually renewable Corporate Services
Agreement with BGLS wherein BGLS agreed to provide corporate services to the
Company at an annual fee paid in monthly installments. Corporate services
provided by BGLS under this agreement include the provision of administrative
services related to Liggett's participation in its parent company's
multi-employer benefit plan, external publication of financial results,
preparation of consolidated financial statements and tax returns and such other
administrative and managerial services as may be reasonably requested by
Liggett. The charges for services rendered under the agreement amounted to $918
in the first six months of 1998 and $1,659 in the first six months of 1997. This
fee is in addition to the management fee and overhead reimbursements described
above. In connection with the January 30, 1998 amendment to the Liggett Notes
Indenture, BGL and BGLS agreed to waive corporate services and management fees
above $3,600 per year, effective January 1, 1998.
Since April 1994, the Company has leased equipment from BGLS for $50
per month.
10. RESTRUCTURING CHARGES
During 1997, the Company reduced its headcount by 108 full-time
positions and recorded a $1,964 restructuring charge to operations ($407 of
which was included in cost of sales) for severance programs, primarily salary
continuation and related benefits for terminated employees. Of the total
restructuring recorded during 1997, $1,671 was funded during 1997, leaving $293
remaining to be funded in 1998.
22
23
For the six months ending June 30, 1998, restructuring charges of
approximately $241 were funded, leaving $52 to be funded in the remainder of
1998.
23
24
EVE HOLDINGS INC.
BALANCE SHEETS
(Unaudited)
(Dollars in thousands, except per share amounts)
June 30, December 31,
1998 1997
-------- ------------
ASSETS
Cash ........................................................................... $ 4 $ 1
Office equipment ............................................................... 2 2
Trademarks, at cost, less accumulated amortization of
$19,845 and $18,995, respectively .......................................... 568 1,418
-------- --------
Total assets .................................................... $ 574 $ 1,421
======== ========
LIABILITIES AND STOCKHOLDER'S EQUITY (DEFICIT)
Federal income taxes currently payable to parent ............................... $ 73 $ 91
Dividends payable .............................................................. 1,318 1,273
Other current liabilities ...................................................... -- 3
Deferred income taxes .......................................................... 199 496
-------- --------
Total liabilities ................................................ 1,590 1,863
-------- --------
Stockholder's equity (deficit):
Common stock (par value $1.00 per share; authorized,
issued and outstanding 100 shares) and contributed
capital ................................................................ 48,041 45,442
Receivables from parent:
Note receivable - interest at 14%, due no sooner
than February 1, 1999 ................................................. (44,520) (44,520)
Other ................................................................... (4,537) (1,364)
-------- --------
Total stockholder's equity (deficit) ............................. (1,016) (442)
-------- --------
Total liabilities and stockholder's equity (deficit).............. $ 574 $ 1,421
======== ========
The accompanying notes are an integral
part of these financial statements.
24
25
EVE HOLDINGS INC.
STATEMENTS OF OPERATIONS
(Unaudited)
(Dollars in thousands)
Three Months Ended Six Months Ended
June 30, June 30,
------------------ ------------------
1998 1997 1998 1997
------ ------ ------ ------
Revenues:
Royalties - parent ............ $2,052 $1,761 $3,571 $3,306
Interest - parent ............. 1,577 1,576 3,153 3,153
------ ------ ------ ------
3,629 3,337 6,724 6,459
Expenses:
Amortization of trademarks .... 426 425 851 851
Miscellaneous, net ............ 24 27 39 64
------ ------ ------ ------
Income before income taxes 3,179 2,885 5,834 5,544
Income tax provision ............... 562 458 939 837
------ ------ ------ ------
Net income ............... $2,617 $2,427 $4,895 $4,707
====== ====== ====== ======
The accompanying notes are an integral
part of these financial statements.
25
26
EVE HOLDINGS INC.
STATEMENTS OF CASH FLOWS
(Unaudited)
(Dollars in thousands)
Six Months Ended
June 30,
---------------------
1998 1997
------- -------
Cash flows from operating activities:
Net income ............................................................. $ 4,895 $ 4,707
Adjustments to reconcile net income to net cash provided by
operating activities:
Depreciation and amortization ...................................... 851 851
Deferred income taxes .............................................. (297) (298)
Changes in assets and liabilities:
Federal income taxes currently payable to parent ................... (18) 74
Other current liabilities .......................................... (3) (16)
------- -------
Net cash provided by operating activities ...................... 5,428 5,318
------- -------
Cash flows from financing activities:
Dividends/capital distributions ........................................ (2,252) (5,603)
Decrease (increase) in due from parent ................................. (3,173) 387
Decrease in cash overdraft ............................................. -- (92)
------- -------
Net cash used in financing activities ........................... (5,425) (5,308)
Net increase in cash ....................................................... 3 10
Cash:
Beginning of period .................................................... 1 --
------- -------
End of period .......................................................... $ 4 $ 10
======= =======
Supplemental cash flow information:
Payments of income taxes through receivable from parent ................ $ -- $ 1,060
Income taxes ........................................................... 74 32
Dividends/capital distributions declared but not paid .................. 2,295 1,127
The accompanying notes are an integral
part of these financial statements.
26
27
EVE HOLDINGS INC.
NOTES TO FINANCIAL STATEMENTS
(Unaudited)
(Dollars in thousands, except per share amounts)
1. THE COMPANY
Eve Holdings Inc. ("Eve") is a wholly-owned subsidiary of Liggett Group
Inc. ("Liggett"). Eve, formed in June 1990, is the proprietor of, and has all
right, title and interest in, certain federal trademark registrations (the
"Trademarks"). Eve has entered into an exclusive licensing agreement with
Liggett (effective until 2010) whereby Eve grants the use of the Trademarks to
Liggett in exchange for royalties, computed based upon Liggett's annual net
sales, excluding excise taxes. The Trademarks are pledged as collateral for
Liggett's borrowings under the notes indentures (see Note 3).
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
a. Going Concern
The accompanying financial statements have been prepared assuming that
Eve will continue as a going concern. Eve's revenues are comprised solely of
royalties and interest income from Liggett. In addition, Eve holds a note
receivable from Liggett for $44,520 due no sooner than February 1, 1999. Liggett
had a working capital deficiency of $176,784 and a net capital deficiency of
$188,372 as of June 30, 1998, is highly leveraged and has substantial near-term
debt service requirements. Both the Liggett Series B and Series C Notes (as
defined below) and the revolving credit facility, amounting in total to
approximately $167,500, mature during the first quarter of 1999. These matters
raise substantial doubt about Eve and Liggett meeting their liquidity needs and
their ability to continue as going concerns.
The financial statements do not include any adjustments that might
result from the outcome of this uncertainty.
b. Per Share Data
All of Eve's common shares (100 shares authorized, issued and
outstanding for all periods presented herein) are owned by Liggett. Accordingly,
earnings and dividends per share data are not presented in these financial
statements.
3. GUARANTEE OF LIGGETT NOTES
On February 14, 1992, Liggett issued $150,000 of Senior Secured Notes
(the "Series B Notes"). In connection with the issuance of the Series B Notes,
the Trademarks were pledged as collateral. In addition, Eve is a guarantor for
the Series B Notes. At June 30, 1998, a total of $112,612 Series B Notes remains
outstanding.
During 1994, Liggett issued $32,850 of Series C Senior Secured Notes
(the "Series C Notes"). Eve is a guarantor for the Series C Notes. At June 30,
1998, a total of $32,279 Series C Notes remains outstanding.
27
28
4. INCOME TAXES
Eve qualifies as a company conducting operations exempt from income
taxation under Delaware General Statute Section 1903(b). In recent years, some
states have been aggressively pursuing companies exempt under this statute.
Eve's management believes that certain state income tax rulings supporting these
states' arguments will be ultimately reversed and that Eve's status as a company
not conducting business in these states will be respected. Consequently,
management has not provided a reserve for additional state income taxes. No
assurance can be given with regard to future state income tax rulings and audit
activity with respect to Eve.
28